Table 3. Comparison of clinical character of EHPVO patients with or without MPN.
| Variable | MPN (n = 4) | without MPN (n = 11) | p |
|---|---|---|---|
| Gender (Male/Female) | 1/3 | 6/5 | NS |
| Age at initial symptom | |||
| mean ± SD | 54.3 ± 10.0 | 37.2 ± 18.9 | NS |
| (range) | (42-66) | (5-74) | |
| BMI kg/m2 | |||
| mean ± SD | 20.6 ± 1.7 | 24.6 ± 4.4 | NS |
| WBC (×103/μL) | |||
| mean ± SD | 9.7 ± 1.2 | 4.4 ± 1.6 | < 0.05 |
| RBC (×106/μL) | |||
| mean ± SD | 4.4 ± 1.4 | 4.6 ± 0.4 | NS |
| Platelet (×104/μL) | |||
| mean ± SD | 35.2 ± 9.2 | 13.6 ± 7.0 | < 0.05 |
| Antithrombin III % (80-120) | |||
| mean ± SD | 88.7 ± 10.9 | 89.4 ± 13.8 | NS |
| Protein S % (64-149) | |||
| mean ± SD | 52.9 ± 5.7 | 89.8 ± 18.4 | < 0.05 |
| Protein C % (64-146) | |||
| mean ± SD | 84.5 ± 12.1 | 93.3 ± 30.5 | NS |
| D-dimer ug/mL (< 0.5) | |||
| mean ± SD | 1.20 ± 0.55 | 0.98 ± 0.63 | NS |
| history of vascular disease (yes/no) | 1/3 | 4/7 | NS |
| history of intestinal bleeding (yes/no) | 3/1 | 6/5 | NS |
BMI: body mass index, EHPVO: extrahepatic portal vein obstruction, MPN: myeloproliferative neoplasm, RBC: red blood cell, WBC: white blood cell.